Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $893.32 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2026-08-03
- 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $893.32M.
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $749.32M.
- 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $66.07M.
- 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $86.67M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months as first filed |
|---|---|---|
| 2026-06-30 | $893.32M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $749.32M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $66.07M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $86.67M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $135.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $87.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $232.92M 10-Q · filed 2025-11-06 | $274.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $25.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $322.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $189.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $15.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $151.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $442.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.38M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.15M 10-K · filed 2024-02-28 |